Photo: Neil Grubert/Linkedin
Jun 1, 2023, 03:55
Wide variations in use of innovative oncology drugs across europe
A report by IQVIA reveals that the use of innovative oncology drugs in Europe generally correlates with GDP, but there are exceptions. Western Europe exceeds the European average in volume usage, while Eastern Europe lags behind. Wealthier countries like Ireland and Norway have similar usage rates to the European average, while Austria and France have higher rates. Slovenia stands out with higher usage compared to Spain and the UK. Multiple factors contribute to these differences, including epidemiology, reimbursement decisions, and patient preferences.
Source: Neil Grubert/Linkedin
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 16:25
Nov 13, 2024, 16:23
Nov 13, 2024, 16:08
Nov 13, 2024, 16:02
Nov 13, 2024, 15:56
Nov 13, 2024, 15:46
Nov 13, 2024, 15:32
Nov 13, 2024, 15:29